Advertisement

Pneumokokken und Pneumokokkenimpfstoffe

Bedeutung für die Pädiatrie
  • S. Volz
  • P. Habermehl
  • A. Zell
  • M. Knuf

Zusammenfassung

Die 3 Bakterien Streptococcus pneumoniae, Neisseria meningitidis und Haemophilus influenzae haben gemeinsam,
  • dass ihre Kapsel der wichtigste Pathogenitätsfaktor ist,

  • dass sie den Nasopharynx des Menschen kolonisieren können und

  • dass sie mit jeweils unterschiedlicher Häufigkeit verantwortlich sind für ▸,invasive Infektionskrankheiten“ — Bakteriämie, Sepsis, Meningitis — wie auch für lokale Infektionskrankheiten im Bereich der Atemwege, allen voran für Otitis media und Pneumonie.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    American Academy of Pediatrics (2000) Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 106:362–366CrossRefGoogle Scholar
  2. 2.
    Black S, Shinefield H (1997) Issues and challenges: pneumococcal vaccination in pediatrics. Pediatr Ann 26:355–360PubMedGoogle Scholar
  3. 3.
    Black S, Shinefield H, Firemann B et al. (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis 19:187–195CrossRefGoogle Scholar
  4. 4.
    Dagan R (2000) Effect of vaccine on antibioticresistant Streptococcus pneumoniae carriage and spread [Abstract 072].Second International Symposium of Pneumococci and Pneumococcal Diseases, Sun City, South AfricaGoogle Scholar
  5. 5.
    Dagan R, Engelhard D, Piccard E (1992) Epidemiology of invasive childhood pneumococcal infections in Israel. The Israel Pediatric Bacteremia and Meningitis Group. JAMA 268:3328PubMedCrossRefGoogle Scholar
  6. 6.
    Dagan R, Givon N, Yagupsky P et al. (1998) Effect of an 9-valent pneumococcal vaccine conjugated to CRM197 on nasopharyngeal (NP) carriage of vaccine type and non-vaccine type S.pneumoniae strains among day care center (DCC) attendees [Abstract G-52].38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA,p 29Google Scholar
  7. 7.
    Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M (1992) Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 268:3323PubMedCrossRefGoogle Scholar
  8. 8.
    Fedson DS, Musher DM, Eskola J: Vaccines recommended for adults: pneumococcal vaccine. S 553–607Google Scholar
  9. 9.
    Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA, Detsky AS, Kapoor WN (1994) Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 154:2666–2667PubMedCrossRefGoogle Scholar
  10. 10.
    Global Programme for Vaccines and Immunization (1996) Report of the meeting of the Scientific Group of Experts (SAGE) of the Children’s Vaccine Initiative and the Global Programmes for Vaccines and Immunization. WHO, GenfGoogle Scholar
  11. 11.
    Kilpi T, Palmu A, Leinonen M, Eskola J, Finom SG (2000) Effect ofasevenvalent pneumococcal conjugate vaccine (PncOMP) against serotype-specific acute otitis media (AOM) caused by Streptococcus pneumoniae (Pnc). Abstract from 40th ICCAC, September 17-20, 2000, Toronto, Ontario, CanadaGoogle Scholar
  12. 12.
    Kries R von (2000) Epidemiologie von Pneumokokkeninfektionen bei Kindern. In: Schmitt HJ (Hrsg) Alte und neue Impfstoffe in Deutschland: Grundlagen für künftige Entscheidungen. Infomed, BerlinGoogle Scholar
  13. 13.
    Kries R von, Seidler A, Schmitt HJ, Reinert RR (2000) Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 31:482–487CrossRefGoogle Scholar
  14. 14.
    Levine OS, Farley M, Harrison LH, Lefkowitz L, McGeer A, Schwartz B (1999) Risk factors for invasive pneumococcal disease in children: a population based case control study in North America. Pediatrics 103: E28PubMedCrossRefGoogle Scholar
  15. 15.
    Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman K (1999) Immunogenecity and impact on nasopharyngeal carriage of a nonavalent conjugate vaccine. J Infect Dis 180:1171–1176PubMedCrossRefGoogle Scholar
  16. 16.
    Recommendations of Advisory Committee on Immunization Practices (ACIP) (1997) Preventing of pneumococcal disease. MMWR Morb Mortal Wkly Rep 46/RR8:1–24Google Scholar
  17. 17.
    Recommendations of Advisory Committee on Immunization Practices (ACIP) (2000) preventing pneumococcal disease among infants and young children. MMWR Morb Mortal Wkly Rep 49/RR-9Google Scholar
  18. 18.
    Reinert RR, Kühnemund O (1999) Neue Daten zu Pneumokokkeninfektion. Immunologie Impfen 3:122–127CrossRefGoogle Scholar
  19. 19.
    Reinert RR, Kaufhold A, Schlaeger JJ, Mechery V, Lutticken R (1997) Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates causing systemic infections among children in Germany, 1992 to 1996. Pediatr Infect Dis J16: 244–245Google Scholar
  20. 20.
    Robbins et al. (1979) Comperative immunogenecity of group 6 pneumococcal type 6A and type 6B capsular polysaccharides. Infect Immun 26:1116–1122PubMedGoogle Scholar
  21. 21.
    Schmöle Thoma B (2000) Sieben-valente Pneumokokken Konjugatimpfstoff (7VpnC-Prevenar). Immunogenität, Reaktogenität und Wirksamkeit. In: Schmitt HJ (Hrsg) Alte und neue Impfstoffe in Deutschland: Grundlagen für künftige Entscheidungen. Infomed, BerlinGoogle Scholar
  22. 22.
    Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI (1996) Epidemiology of invasive disease in Southern California: implications for the design and conduct of pneumococcal conjugate vaccine efficacy trial. J Infect Dis 174:752PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • S. Volz
    • 1
  • P. Habermehl
    • 1
  • A. Zell
    • 1
  • M. Knuf
    • 1
  1. 1.Pädiatrische Infektiologie, Zentrum für Präventive PädiatrieJohannes-Gutenberg-Universität MainzMainzDeutschland

Personalised recommendations